GH
AMRI

GAM Holding’s Albany Molecular Research Inc AMRI Stock Holding History

GAM Holding’s Portfolio AMRI Stock Details AMRI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-95,000
Closed -$2.06M – 1036
2017
Q2 		$2.06M Buy
+95,000
New +$1.72M 0.03% 491

Other funds holding AMRI

AA
Ancora Advisors Cleveland, Ohio $4.7B AUM 19.05% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

GAM Holding's AMRI Position: Q3 2017 in Review

GAM Holding sold out of Albany Molecular Research Inc (AMRI) in Q3 2017, closing a stake of 95,000 shares — an estimated $2.06M sold.

GAM Holding first reported a position in AMRI in Q2 2017 and held it in 1 quarter. The position peaked at $2.06M in Q2 2017. 2 funds tracked by Wall St. Rank hold AMRI as of Q3 2017.

  • GAM Holding reported no remaining Albany Molecular Research Inc position as of Q3 2017 after selling out during the quarter.
  • GAM Holding sold 95,000 Albany Molecular Research Inc shares in Q3 2017, an estimated $2.06M.
  • GAM Holding first reported a position in Albany Molecular Research Inc in Q2 2017 and held it in 1 quarter.
  • GAM Holding's Albany Molecular Research Inc position peaked at $2.06M in Q2 2017.
  • 2 funds tracked by Wall St. Rank held Albany Molecular Research Inc as of Q3 2017.

Based on GAM Holding's 13F filing for Q3 2017, filed 14 Nov 2017.